Paul A Friedman's Net Worth

Paul A Friedman's net worth is estimated to be at least $89,063,581.36 as of 11/22/2024. CoreStreet's estimation of Paul A Friedman's net worth is based on their sale of stock and current holding of stock.

Paul A Friedman is Director at Madrigal Pharmaceuticals Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 26,270 units of MDGL stock on 04/08/2024. Their biggest sale was on 05/27/2015 when they sold 196,751 units of Incyte Corporation stock for $21,097,609.73. They typically trade 1 times per year.

Total value of insider buys:
  • $520,930.00
Total value of insider sells:
  • $88,542,651.36
Most recent insider trade:
  • April 8, 2024

Paul A Friedman's Insider Trading History

Madrigal Pharmaceuticals IncTitleAmountPriceTypeTotal Value
April 8, 2024
Director26,270$246.19Sell$6,467,411.30
April 4, 2024
Director18,710$242.96Sell$4,545,781.60
Nov. 19, 2018
CEO4,000$124.00Buy$496,000.00
Incyte CorporationTitleAmountPriceTypeTotal Value
Aug. 6, 2019
Director100,000$82.69Sell$8,269,000.00
Nov. 16, 2017
Director28,507$105.24Sell$3,000,076.68
March 17, 2017
Director50,000$148.72Sell$7,436,000.00
May 27, 2015
Director196,751$107.23Sell$21,097,609.73
May 22, 2015
Director102,243$108.22Sell$11,064,737.46
Nov. 6, 2014
Director185,653$67.87Sell$12,600,269.11
Sept. 10, 2013
CEO376,789$37.32Sell$14,061,765.48
Verastem IncTitleAmountPriceTypeTotal Value
Dec. 24, 2014
Director3,000$8.31Buy$24,930.00